management will provide a brief overview of the company followed by a
question and answer period with investors at the following investor
conferences during the month of February:
February 16, at 9:30 a.m. ET– Leerink Swann2012 Global Healthcare
New York City; and
February 27, at 11:30 a.m. ET– Citi 2012 Global Healthcare Conference
New York City.
A live webcast of each presentation will be accessible through the
Investors section of the company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the
development and commercialization of a therapeutic iron compound to
treat iron deficiency anemia. For additional company information, please
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303